Authors:
MARCUSSON J
ROTHER M
KITTNER B
ROSSNER M
SMITH RJ
BABIC T
FOLNEGOVICSMALC V
MOLLER HJ
LABS KH
Citation: J. Marcusson et al., A 12-MONTH, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROPENTOFYLLINE (HWA-285) IN PATIENTS WITH DEMENTIA ACCORDING TO DSM III-R, Dementia and geriatric cognitive disorders, 8(5), 1997, pp. 320-328
Authors:
TSCHOPL M
TSAKIRIS DA
MARBET GA
LABS KH
JAGER K
Citation: M. Tschopl et al., ROLE OF HEMOSTATIC RISK-FACTORS FOR RESTENOSIS IN PERIPHERAL ARTERIALOCCLUSIVE DISEASE AFTER TRANSLUMINAL ANGIOPLASTY, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3208-3214
Authors:
VANDENBRANDE P
MUNCK D
WAUTRECHTS J
DEROOSE J
DEPUYDT P
JOERGENSEN SJ
LABS KH
GOUGH M
GALLOWAY JMD
KESTER RC
WAKE P
LEVESON SH
COLGAN MP
MOORE D
SHANIK G
KNIPPENBERG B
GRAVENHAGE S
ORTENWALL P
RISBERG B
KONRAD P
MOLDE A
LUNDQVIST B
SPANGEN L
EMTERSJO G
THOMSEN MB
BERGQVIST D
LUNDELL A
ANGQVIST KA
HEDBERG B
BJORKMAN H
WEBER P
MCQUAY HJ
WREN MWG
PROUT G
Citation: P. Vandenbrande et al., INTRAVENOUS PENTOXIFYLLINE FOR THE TREATMENT OF CHRONIC CRITICAL LIMBISCHEMIA, European journal of vascular and endovascular surgery, 9(4), 1995, pp. 426-436
Citation: Kh. Labs et T. Pischel, VASCULAR TRAINING WITH DRUG-THERAPY IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, Circulation, 91(10), 1995, pp. 2681-2681